Live from the 6th annual Vit-Buckle Society meeting, Drs. Tom Albini, Andrew Moshfeghi and Charlie Wykoff join the show to discuss a hot issue in retina today: the aflibercept-associated idiopathic ocular inflammation cases that have been reported throughout the country over the past few months.
Relevant financial disclosures: Dr. Albini has no relevant financial disclosures. Dr. Moshfeghi is a consultant for Regeneron. Dr. Wykoff is a speaker and consultant for Regeneron.
CME Information
Release: Mar. 24, 2018; expires Mar. 24, 2021
Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.